Skip to content
Riskpilot
← Back to search
Sign in
Get full access
GlyProVac ApS
APS
Active
CVR 39724758
Rørhatten 4, 5220
Odense SØ
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2018 · 7 years old
7 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
GlyProVac ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
-1M
2023
-1M
2024
-2M
2025
EBITDA
DKK millions
0M
-2M
-4M
-6M
-8M
-1M
2021
-1M
0%
2022
-3M
-200%
2023
-3M
0%
2024
-6M
-100%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
993
1.321
-815
-577
-2.129
Staff expenses
-1.724
-2.181
-2.294
-2.894
-3.760
EBITDA
-731
-860
-3.109
-3.471
-5.889
Depreciation & amort.
-0
-0
-10
-12
-12
EBIT
-731
-860
-3.119
-3.483
-5.902
Net financials
-195
-206
-277
-379
-361
Profit before tax
-926
-1.066
-3.396
-3.862
-6.262
Tax
-439
-432
-524
-847
-1.093
Net profit
-487
-633
-2.872
-3.015
-5.169
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
9.529
12.232
5.513
4.391
4.634
Equity
2.435
4.977
852
-654
-832
Long-term debt
4.407
3.901
4.171
4.559
4.932
Short-term debt
2.127
2.525
490
485
534
Total debt
6.534
6.427
4.662
5.044
5.466
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-588926600.0%
This company
2021
2025
Equity ratio
-17.9%
This company
38.2%
Market median
-147% vs market
2021
2025
Return on equity
-516899900.0%
This company
18.4%
Market median
-2809238687% vs market
2021
2025
Net profit margin (of gross profit)
-516899900.0%
This company
2021
2025
Asset turnover (of gross profit)
-0.46×
This company
2021
2025
Debt / equity
6.57×
This company
0.62×
Market median
-960% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
More on GlyProVac ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
